Capromorelin tartrate has been used in human clinical trials as a treatment for frailty in elderly adults.
[1]Capromorelin tartrate is an agonist of GHSR1a (ghrelin) receptors. It possesses structural homology with pyrazolinone-piperidine dipeptides.
[2]